Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
310.71
+0.13 (0.04%)
At close: Mar 6, 2026, 4:00 PM EST
310.86
+0.15 (0.05%)
After-hours: Mar 6, 2026, 7:59 PM EST
PRAX Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | - | 8.55 | 2.45 | - | - | |
| Revenue Growth (YoY) | - | 249.53% | - | - | - | |
| Cost of Revenue | 267.12 | 152.41 | 86.77 | 154.44 | - | |
| Gross Profit | -267.12 | -143.86 | -84.32 | -154.44 | - | |
| Selling, General & Admin | 59.08 | 56.31 | 42.05 | 59.55 | 47.08 | |
| Research & Development | - | - | - | - | 120.26 | |
| Operating Expenses | 59.08 | 56.31 | 42.05 | 59.55 | 167.33 | |
| Operating Income | -326.2 | -200.17 | -126.37 | -213.99 | -167.33 | |
| Interest & Investment Income | 19.34 | 12.34 | 3.14 | 1.96 | 2.36 | |
| EBT Excluding Unusual Items | -306.86 | -187.83 | -123.23 | -212.03 | -164.97 | |
| Merger & Restructuring Charges | - | - | - | -1 | - | |
| Gain (Loss) on Sale of Investments | 3.59 | 5.01 | -0.05 | -1 | -2.09 | |
| Pretax Income | -303.27 | -182.82 | -123.28 | -214.03 | -167.06 | |
| Net Income | -303.27 | -182.82 | -123.28 | -214.03 | -167.06 | |
| Net Income to Common | -303.27 | -182.82 | -123.28 | -214.03 | -167.06 | |
| Shares Outstanding (Basic) | 23 | 18 | 7 | 3 | 3 | |
| Shares Outstanding (Diluted) | 23 | 18 | 7 | 3 | 3 | |
| Shares Change (YoY) | 25.68% | 171.55% | 114.58% | 8.58% | 374.34% | |
| EPS (Basic) | -13.48 | -10.21 | -18.69 | -69.65 | -59.03 | |
| EPS (Diluted) | -13.48 | -10.21 | -18.69 | -69.65 | -59.03 | |
| Free Cash Flow | -249.12 | -131.76 | -111.19 | -185.49 | -125.6 | |
| Free Cash Flow Per Share | -11.07 | -7.36 | -16.86 | -60.36 | -44.38 | |
| Operating Margin | - | -2340.29% | -5164.40% | - | - | |
| Profit Margin | - | -2137.48% | -5037.88% | - | - | |
| Free Cash Flow Margin | - | -1540.48% | -4543.77% | - | - | |
| EBITDA | -326.06 | -199.81 | -125.94 | -213.57 | -167.15 | |
| D&A For EBITDA | 0.14 | 0.36 | 0.43 | 0.42 | 0.18 | |
| EBIT | -326.2 | -200.17 | -126.37 | -213.99 | -167.33 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.